Silverback Asset Management »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Silverback Asset Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Silverback Asset Management from 13F filings

Historical chart of Silverback Asset Management investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Silverback Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Silverback Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $8.0B 7.5M 1068.14